Learning about reducing medicines risk - Antipsychotics

We have recently launched a learning module on antipsychotics for clinical practitioners. The self-directed learning package outlines the key risks of this widely prescribed class of medicines. For each adverse effect, the module outlines:

• The main features of the adverse effect
• Factors that increase the risk
• How the risk can be reduced
• Specific treatment for the adverse effect

Self-assessment questions, together with full feedback, complement the learning material. Learners tell us that they greatly value the questions and the accompanying detailed feedback. Responding to comments on an earlier module on opioids we have increased the number of questions included in this module.

We have included a short online evaluation form at the end of the module—responses will help us tailor the modules to users' needs.

The antipsychotics learning module joins similar ones on selective serotonin reuptake inhibitors (SSRIs) and opioids .

The education page on our website lists other learning materials and gives information on obtaining continuing professional development (CPD) credits.

Article citation: Drug Safety Update October 2012, vol 6, issue 3: O1.